QUEBEC CITY, Sept. 27 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS) today announced that Gilles Gagnon, President and Chief Executive Officer of the Company, will present a corporate update at Bio Contact on Thursday, October 5, 2006, at 9:30 a.m. ET, in the Frontenac Room of the Fairmont Le Chateau Frontenac Hotel in Quebec City, Canada. Mr. Gagnon will also present a corporate update at Bio Investor Forum on Wednesday, October 18, 2006 at 1:00 p.m. Pacific Time, in the Twin Peaks South Room of the Palace Hotel in San Francisco. A live webcast of this presentation will be available on AEterna Zentaris' website at http://www.aeternazentaris.com/ in the Investors section. A replay will also be available for a period of 60 days. About AEterna Zentaris Inc. AEterna Zentaris Inc. is a growing global biopharmaceutical company focused on endocrine therapy and oncology, with proven expertise in drug discovery, development and commercialization. AEterna Zentaris also owns 48.3% of the equity of Atrium Biotechnologies Inc. (TSX: ATB) and 64.7% of its voting rights. Atrium is a developer, manufacturer and marketer of science-based products for the cosmetics, pharmaceutical, chemical and nutritional industries. News releases and additional information are available at http://www.aeternazentaris.com/. DATASOURCE: AETERNA ZENTARIS INC. (FORMERLY/ANCIENNEMENT - LES LABORATOIRES AETERNA LABORATORIES INC.) CONTACT: Media Relations: Paul Burroughs, (418) 652-8525 ext. 406, ; Investor Relations: Jenene Thomas, (418) 655-6420 or (908) 996-3154,

Copyright